FBRX

Forte Biosciences Stock Analysis

AI Rating

Good
  • Quality2/10
  • Growth 8/10
  • Momentum 9/10
Forte Biosciences sales and earnings growth
FBRX Growth
Good
  • Revenue Y/Y 0.00%
  • EPS Y/Y 99.14%
  • FCF Y/Y -49.93%
Forte Biosciences gross and profit margin trends
FBRX Profitability
Low
  • Gross margin 0.00%
  • EPS margin 0.00%
  • ROIC -3473.20%
Forte Biosciences net debt vs free cash flow
FBRX Risk
Great
  • Debt / Equity 0.0
  • Debt / FCF 0.0
  • Interest coverage NA

Forte Biosciences stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗